carbidopa has been researched along with Adjuvant Arthritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhatt, B; Browning, DD; Fulzele, S; Gurav, A; Huang, L; Islam, BN; Lemos, H; Mellor, A; Singh, A; Singh, N; Zhu, H | 1 |
1 other study(ies) available for carbidopa and Adjuvant Arthritis
Article | Year |
---|---|
Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.
Topics: Animals; Antiparkinson Agents; Arthritis, Experimental; Autoimmune Diseases; Autoimmunity; Carbidopa; Cytokines; Disease Models, Animal; Dopamine Agents; Encephalomyelitis, Autoimmune, Experimental; Inflammation Mediators; Lymphocyte Activation; Lymphocyte Count; Macrophages; Mice; T-Lymphocyte Subsets; T-Lymphocytes | 2017 |